Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Current Portion of Long-Term Debt
Abbott Laboratories
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Current Portion of Long-Term Debt
$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
167%
|
CAGR 10-Years
63%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Current Portion of Long-Term Debt
$2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
26%
|
|
Boston Scientific Corp
NYSE:BSX
|
Current Portion of Long-Term Debt
$531m
|
CAGR 3-Years
244%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
68%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Current Portion of Long-Term Debt
$2.1B
|
CAGR 3-Years
40%
|
CAGR 5-Years
9%
|
CAGR 10-Years
56%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
1.1B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Current Portion of Long-Term Debt amounts to 1.1B USD.
What is Abbott Laboratories's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
63%
Over the last year, the Current Portion of Long-Term Debt growth was -53%. The average annual Current Portion of Long-Term Debt growth rates for Abbott Laboratories have been 13% over the past three years , 167% over the past five years , and 63% over the past ten years .